Interferon beta treatment in relapsing-remitting multiple sclerosis. A review.
B' Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Stilp Kyriakidi Str. 1, GR-54636 Thessaloniki, Greece. grigoria@med.auth.gr
Nikolaos
N
Grigoriadis
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000917:Antibody Formation; D002908:Chronic Disease; D018450:Disease Progression; D004334:Drug Administration Schedule; D006801:Humans; D016899:Interferon-beta / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology*; D010347:Patient Care Planning; D012008:Recurrence
D000276:Adjuvants, Immunologic; D016899:Interferon-beta